EconPapers    
Economics at your fingertips  
 

Potential Effects of Resveratrol on Obesity Markers of Iraqi Women

Wameedh Ali Mahmood Al Nuaimi and Adawiya Ali Mahmood Al-Nuaimi
Additional contact information
Wameedh Ali Mahmood Al Nuaimi: Ministry of Health / General Hospital of Samarra, Iraq
Adawiya Ali Mahmood Al-Nuaimi: Applied Mathematics, Department of Mathematics, College of Science, University of Diyala, Iraq

European Journal of Medicine and Natural Sciences, 2025, vol. 8, issue 2, 29-33

Abstract: Obesity is defined as a condition of chronic oxidative stress and chronic systemic inflammation, and it is associated with many health problems. Resveratrol is a polyphenolic compound noted to exert beneficial effects on various diseases such as cardiovascular diseases, atherosclerosis, diabetes mellitus, and nephropathy. The healthful effects of resveratrol are thought to be attributed to its antioxidant properties. In this interventional prospective randomized controlled trial, female patients diagnosed with obesity according to the WHO criteria and were randomly allocated to either control or resveratrol group. Resveratrol supplement showed a significant reduction in weight, body mass index (BMI) and waist circumference (WC). From the above results, one can conclude that oral supplementation of resveratrol can improve Anthropometric parameters.

Keywords: obesity; resveratrol; body mass index. (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://mentisia.org/files/articles/ejmn_v8_i2_25/Nuaimi.html (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eur:ejmnjr:162

Access Statistics for this article

More articles in European Journal of Medicine and Natural Sciences from Mentisia
Bibliographic data for series maintained by Mentisia ().

 
Page updated 2026-10-25
Handle: RePEc:eur:ejmnjr:162